B, A., W, A., S, I., & P, B. (2024). Dapagliflozin in Heart Failure: A Comprehensive Meta-analysis on Functional Capacity, Symptoms, and Safety Outcomes. American journal of cardiovascular drugs : drugs, devices, and other interventions, 24(6), 753. https://doi.org/10.1007/s40256-024-00669-x
Chicago Style (17th ed.) CitationB, Addo, Agyeman W, Ibrahim S, and Berchie P. "Dapagliflozin in Heart Failure: A Comprehensive Meta-analysis on Functional Capacity, Symptoms, and Safety Outcomes." American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions 24, no. 6 (2024): 753. https://doi.org/10.1007/s40256-024-00669-x.
MLA (9th ed.) CitationB, Addo, et al. "Dapagliflozin in Heart Failure: A Comprehensive Meta-analysis on Functional Capacity, Symptoms, and Safety Outcomes." American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions, vol. 24, no. 6, 2024, p. 753, https://doi.org/10.1007/s40256-024-00669-x.